Federal News
Senator Young Advocates U.S. Biotech Leadership
March 25, 2026
Senator Todd Young, Chairman of the National Security Commission on Emerging Biotechnology (NSCEB), emphasized the urgent need for the United States to maintain and accelerate leadership in biotechnology to ensure national security and outpace China. Speaking at the Hill & Valley Forum in Washington, D.C., Young highlighted the commission's comprehensive report and action plan as a roadmap for swift government action and investment in emerging biotech capabilities. This focus signals potential increased federal funding, strategic initiatives, and procurement opportunities aimed at advancing U.S. biotech innovation and security.
- Why this matters: Procurement professionals should anticipate expanded federal biotech programs and funding streams driven by national security priorities.
- Agencies like ARPA-H may increase solicitations for cutting-edge biotech research and development contracts.
- Contractors and industry stakeholders can position themselves to support government efforts by aligning with emerging biotech technologies and national security objectives.
- This development underscores the strategic importance of biotechnology in federal acquisition planning and cross-agency collaboration.
Young spoke with Fox Business about the national security implications of AI and why the U.S. must stay ahead.
— Todd Young, U.S. Senator
Agencies
National Security Commission on Emerging Biotechnology, Advanced Research Projects Agency for Health, U.S. Senate
Locations
Sources
- Young Speaks at Hill & Valley Forum on Why U.S. Must Beat China in BioTech - Senator Young · Young Senate · Mar 25